ArrowMark Financial (BANX) vs BlackRock Health Sciences Term (BMEZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
BlackRock Health Sciences Term (BMEZ) has outperformed ArrowMark Financial (BANX) over the past year, gaining 11.9% versus a loss of 10.2%. Over five years, BANX leads with a -12.4% price change compared with -39.5% for BMEZ. BlackRock Health Sciences Term is the larger company by market cap ($1.03 billion vs $190.0 million), about 5.4 times the size.
On valuation, BlackRock Health Sciences Term trades at a lower trailing P/E (4.9x vs 18.3x for ArrowMark Financial). ArrowMark Financial pays a dividend yielding 9.18%, while BlackRock Health Sciences Term does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BANX | BMEZ |
|---|---|---|
| Share price | $19.61 | $16.53 |
| Market cap | $190.00M | $1.03B |
| 1-day change | -1.90% | +0.92% |
| YTD return | -10.13% | +9.83% |
| 1-year return | -10.21% | +11.92% |
| 5-year return | -12.38% | -39.54% |
| P/E ratio (TTM) | 18.33 | 4.88 |
| Forward P/E | 8.64 | — |
| EPS (TTM) | $1.07 | $3.39 |
| Dividend yield | 9.18% | 8.06% |
| Annual dividend | $1.80 | $0.00 |
| 52-week high | $22.50 | $17.25 |
| 52-week low | $18.45 | $13.70 |
| Distance from 52-week high | -12.84% | -4.17% |
| Average volume | 37.46K | 141.71K |
| Shares outstanding | 9.69M | 62.50M |
| Sector | Finance | Finance |
| Industry | Trusts Except Educational Religious and Charitable | Trusts Except Educational Religious and Charitable |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BlackRock Health Sciences Term is about 5.4 times larger than ArrowMark Financial by market value ($1.03B vs $190.00M).
- BMEZ has outperformed BANX by 22.1 percentage points over the past year.
- ArrowMark Financial trades at a higher earnings multiple (18.3x vs 4.9x trailing P/E).
- ArrowMark Financial offers a meaningfully higher dividend yield (9.18% vs 8.06%).
BANX vs BMEZ FAQ
Which is bigger, ArrowMark Financial or BlackRock Health Sciences Term?
BlackRock Health Sciences Term (BMEZ) is larger, with a market capitalization of $1.03B compared with $190.00M for ArrowMark Financial (BANX).
Which stock has performed better over the past year, BANX or BMEZ?
BMEZ returned +11.92% over the past 12 months, compared with -10.21% for BANX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BANX or BMEZ?
BMEZ has the lower trailing P/E at 4.9, versus 18.3 for BANX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, ArrowMark Financial or BlackRock Health Sciences Term?
ArrowMark Financial has the higher yield at 9.18%, compared with 8.06% for BlackRock Health Sciences Term.
Are ArrowMark Financial and BlackRock Health Sciences Term in the same industry?
Yes. Both are classified in the Trusts Except Educational Religious and Charitable industry within the Finance sector.